Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV002251356 | SCV000395527 | likely benign | Familial juvenile hyperuricemic nephropathy type 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000964011 | SCV001111190 | benign | not provided | 2024-11-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000964011 | SCV001983833 | uncertain significance | not provided | 2021-10-22 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Prevention |
RCV004544570 | SCV004771804 | likely benign | UMOD-related disorder | 2019-04-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |